Parsippany, NJ, United States of America

Viyyoor Moopil Girijavallabhan

USPTO Granted Patents = 130 


 

Average Co-Inventor Count = 5.7

ph-index = 24

Forward Citations = 1,556(Granted Patents)


Inventors with similar research interests:


Location History:

  • East Orange, NJ (US) (1978 - 1981)
  • Bloomfield, NJ (US) (1981)
  • Parsipppany, NJ (US) (1989)
  • Parsipanny, NJ (US) (1991)
  • Parippany, NJ (US) (2008)
  • Parsippany, NJ (US) (1983 - 2014)

Company Filing History:


Years Active: 1978-2014

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cyclin Dependent Kinase Inhibitors
Hepatitis C Virus
Ns3 Serine Protease Inhibitors
Pyrazolopyrimidines
Farnesyl Protein Transferase Inhibitors
Antitumor Agents
Peptidomimetic Inhibitors
17Β-Hydroxysteroid Dehydrogenase Inhibitors
Antiviral Agents
Ketoamides
Imidazopyridines
Triazoles
130 patents (USPTO):Explore Patents

Title: Unveiling the Innovative Spirit of Viyyoor Moopil Girijavallabhan

Introduction:

Viyyoor Moopil Girijavallabhan, a prolific inventor based in Parsippany, NJ (US), has made significant contributions to the field of medical research with a remarkable portfolio of 130 patents under his belt.

Latest Patents:

Among his recent patents, one notable invention is the development of "Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors." This breakthrough method offers a novel approach to inhibiting cyclin dependent kinases and treating diseases associated with CDKs. Another groundbreaking patent signifies his work on "Peptides as NS3-serine protease inhibitors of hepatitis C virus," presenting innovative compounds and compositions for combating HCV protease-related disorders.

Career Highlights:

Viyyoor Moopil Girijavallabhan's career has been marked by his tenure at esteemed companies such as Schering Corporation and Pharmacopeia Drug Discovery, Inc. His expertise and dedication have been instrumental in driving forward cutting-edge research and development initiatives in the pharmaceutical industry.

Collaborations:

Throughout his career journey, Viyyoor Moopil Girijavallabhan has collaborated with industry stalwarts such as Ashit K Ganguly and Anil K Saksena. These collaborative efforts have led to the expansion of his inventive horizons and the realization of innovative solutions in the realm of medical science.

Conclusion:

In conclusion, Viyyoor Moopil Girijavallabhan stands as a shining example of a visionary inventor whose relentless pursuit of innovation has brought forth transformative advancements in the field of medicine. His multitude of patents and collaborative ventures attest to his unwavering commitment to pushing the boundaries of scientific exploration and delivering impactful solutions for healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…